BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 19727998)

  • 41. Senataxin modulates neurite growth through fibroblast growth factor 8 signalling.
    Vantaggiato C; Bondioni S; Airoldi G; Bozzato A; Borsani G; Rugarli EI; Bresolin N; Clementi E; Bassi MT
    Brain; 2011 Jun; 134(Pt 6):1808-28. PubMed ID: 21576111
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A new model to study neurodegeneration in ataxia oculomotor apraxia type 2.
    Becherel OJ; Sun J; Yeo AJ; Nayler S; Fogel BL; Gao F; Coppola G; Criscuolo C; De Michele G; Wolvetang E; Lavin MF
    Hum Mol Genet; 2015 Oct; 24(20):5759-74. PubMed ID: 26231220
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Senataxin resolves RNA:DNA hybrids forming at DNA double-strand breaks to prevent translocations.
    Cohen S; Puget N; Lin YL; Clouaire T; Aguirrebengoa M; Rocher V; Pasero P; Canitrot Y; Legube G
    Nat Commun; 2018 Feb; 9(1):533. PubMed ID: 29416069
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Some pathogenic SETX variants are partially conserved during evolution.
    Tariq H; Tariq I; Bourinaris T; Houlden H; Naz S
    Gene; 2021 Mar; 771():145360. PubMed ID: 33333218
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Senataxin: A key actor in RNA metabolism, genome integrity and neurodegeneration.
    Giannini M; Porrua O
    Biochimie; 2024 Feb; 217():10-19. PubMed ID: 37558082
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of senataxin in DNA damage and telomeric stability.
    De Amicis A; Piane M; Ferrari F; Fanciulli M; Delia D; Chessa L
    DNA Repair (Amst); 2011 Feb; 10(2):199-209. PubMed ID: 21112256
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ovarian failure in ataxia with oculomotor apraxia type 2.
    Lynch DR; Braastad CD; Nagan N
    Am J Med Genet A; 2007 Aug; 143A(15):1775-7. PubMed ID: 17593543
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Senataxin: Genome Guardian at the Interface of Transcription and Neurodegeneration.
    Groh M; Albulescu LO; Cristini A; Gromak N
    J Mol Biol; 2017 Oct; 429(21):3181-3195. PubMed ID: 27771483
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ataxia-oculomotor apraxia 2 patients show no increased sensitivity to ionizing radiation.
    Nahas SA; Duquette A; Roddier K; Gatti RA; Brais B
    Neuromuscul Disord; 2007 Dec; 17(11-12):968-9. PubMed ID: 17720498
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical and molecular findings of ataxia with oculomotor apraxia type 2 (AOA2) in 5 Tunisian families.
    Hammer MB; El Euch-Fayache G; Nehdi H; Saidi D; Nasri A; Nabli F; Bouhlal Y; Maamouri-Hicheri W; Hentati F; Amouri R
    Diagn Mol Pathol; 2012 Dec; 21(4):241-5. PubMed ID: 23111195
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Unwinding the role of senataxin in neurodegeneration.
    Bennett CL; La Spada AR
    Discov Med; 2015 Feb; 19(103):127-36. PubMed ID: 25725227
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sensorimotor neuronopathy in ataxia with oculomotor apraxia type 2.
    Gazulla J; Benavente I; López-Fraile IP; Modrego P; Koenig M
    Muscle Nerve; 2009 Sep; 40(3):481-5. PubMed ID: 19618424
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ataxia with oculomotor apraxia type 2 caused by a novel homozygous mutation in SETX gene, and literature review.
    Chen S; Du J; Jiang H; Zhao W; Wang N; Ying A; Li J; Chen S; Shen B; Zhou Y
    Front Mol Neurosci; 2022; 15():1019974. PubMed ID: 36438189
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Senataxin, defective in the neurodegenerative disorder ataxia with oculomotor apraxia 2, lies at the interface of transcription and the DNA damage response.
    Yüce Ö; West SC
    Mol Cell Biol; 2013 Jan; 33(2):406-17. PubMed ID: 23149945
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Senataxin, A Novel Helicase at the Interface of RNA Transcriptome Regulation and Neurobiology: From Normal Function to Pathological Roles in Motor Neuron Disease and Cerebellar Degeneration.
    Bennett CL; La Spada AR
    Adv Neurobiol; 2018; 20():265-281. PubMed ID: 29916023
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Familial cognitive impairment with ataxia with oculomotor apraxia.
    Mahajnah M; Basel-Vanagaite L; Inbar D; Kornreich L; Weitz R; Straussberg R
    J Child Neurol; 2005 Jun; 20(6):523-5. PubMed ID: 15996403
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Senataxin, defective in ataxia oculomotor apraxia type 2, is involved in the defense against oxidative DNA damage.
    Suraweera A; Becherel OJ; Chen P; Rundle N; Woods R; Nakamura J; Gatei M; Criscuolo C; Filla A; Chessa L; Fusser M; Epe B; Gueven N; Lavin MF
    J Cell Biol; 2007 Jun; 177(6):969-79. PubMed ID: 17562789
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A missense mutation in PIK3R5 gene in a family with ataxia and oculomotor apraxia.
    Al Tassan N; Khalil D; Shinwari J; Al Sharif L; Bavi P; Abduljaleel Z; Abu Dhaim N; Magrashi A; Bobis S; Ahmed H; Alahmed S; Bohlega S
    Hum Mutat; 2012 Feb; 33(2):351-4. PubMed ID: 22065524
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sensory neuronopathy in ataxia with oculomotor apraxia type 2.
    Gazulla J; Benavente I; López-Fraile IP; Tordesillas C; Modrego P; Alonso I; Pinto-Basto J
    J Neurol Sci; 2010 Nov; 298(1-2):118-20. PubMed ID: 20869730
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Premature ovarian ageing following heterozygous loss of Senataxin.
    Subramanian GN; Lavin M; Homer HA
    Mol Hum Reprod; 2021 Feb; 27(2):. PubMed ID: 33337500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.